获取演示
Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
SV Health Investors

八月 2026

  • Home
  • SV Health Investors

八月 2026的SV Health Investors市场份额分析

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.
成立年份1993
员工51 - 200
年营收$25M - $50M
svhealthinvestors.com
SV Health Investors
SV Health Investors(包含公司地区分支机构)
  • svhealthinvestors.com
    svhealthinvestors.com
查看更多网站流量和参与度信息

SV Health Investors收入截至 八月 2026为 25M - 50M

SV Health Investors主要域名产生的收入

3 年中SV Health Investors主要域名的收入

SV Health Investors主要域名的收入

svhealthinvestors.comsvhealthinvestors.com25M - 50M
使用销售情报查看更多信息

SV Health Investors热门域名的总访问量

了解SV Health Investors市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细
svhealthinvestors.comsvhealthinvestors.com11.3K
使用销售情报查看更多信息

SV Health Investors热门域名的平均访问时长

分析SV Health Investors参与度指标。

过去 3 个月的平均访问时长

子公司明细
svhealthinvestors.comsvhealthinvestors.com00:01:45
使用销售情报查看更多信息

SV Health Investors热门域名的平均页面浏览量

了解SV Health Investors如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细
svhealthinvestors.comsvhealthinvestors.com2.95
使用销售情报查看更多信息

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



SV Health Investors 采用的主要技术

这些是排名前 SV Health Investors 的顶级域名所使用的网站技术(按行业分列)

付款和货币 (4)

社交 (3)

Instagram

Instagram

内容管理系统 (2)

WordPress

WordPress

转化和分析 (2)

Google Analytics

Google Analytics

更多技术

9

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


SV Health Investors 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻SV Health Investors LLP invests into Draig Therapeutics Ltd in Seed.Draig Therapeutics was co-founded by Cardiff University and SV Health Investors which led the seed financing with ICG, and is backed by other healthcare venture firms including Access Biotechnology, Canaan Partners, SR One, Sanofi Ventures and Schroders Capital.
新闻SV Health Investors LLP acquired EpiVax, Inc. on Apr 2nd '26.SV Health Investors, a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk assessments for pharmaceutical and biotech companies.
新闻SV Health Investors LLP invested into Mestag Therapeutics Limited $40M in financing on Mar 17th '26.Cambridge, UK, March 17, 2026 - Mestag Therapeutics ("Mestag"), a biotech company harnessing fibroblast immunology to develop impactful treatments for patients with cancer and inflammatory diseases, today announced the closing of a $40 million financing supported by leading life science investors SV Health Investors, Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc., Forbion, GV (Google Ventures) and Northpond Ventures.

查看 SV Health Investors 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。